Calcitonin gene-related peptide (CGRP) plays a pivotal role in the pathophysiology of migraine and is an important therapeutic target. Monoclonal antibodies that inhibit CGRP binding to its receptor ...

Migraine is a chronic and debilitating neurological condition affecting women 3 to 4 more times than men. Despite an estimated 1.1 billion people being impacted by the condition, the physiological ...

Up to 30% of people with migraines experience an aura phase, a sensation characterized by visual or sensory disturbances such ...

The EMA has endorsed Aquipta, an oral CGRP receptor antagonist, after it showed superior pain relief vs placebo in treating migraine attacks in adults.

In a recent review published in Nutrients, researchers examine the Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs). Study: Linking Migraine to Gut Dysbiosis and ...

Treating migraine before the pain starts: New research shows ubrogepant eases premonitory symptoms, offering hope for millions seeking earlier and more effective relief. Study: Ubrogepant for the ...

This case study explores the management of ovulation-triggered migraine using naturopathic interventions alongside ...